par 165
Pill imprint par 165 has been identified as Benztropine mesylate 1 mg.
Benztropine is used in the treatment of parkinson's disease; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Benztropine 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Benztropine mesylate Images
- Imprint:
-
par 165
- Strength:
- 1 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
lactose monohydrate
microcrystalline cellulose
starch
magnesium silicate
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0165
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00182-1700 | Goldline Laboratories Inc |
| 00904-1056 | Major Pharmaceuticals |
| 63739-0034 | McKesson Packaging Services |
Note: Inactive ingredients may vary.
Advertisement
More Benztropine Mesylate resources
- Benztropine (Wolters Kluwer)
- Benztropine Tablets (Wolters Kluwer)
- benztropine (Cerner Multum)
- benztropine (Micromedex) - Includes Dosage Information
- benztropine Injection (Micromedex) - Includes Dosage Information
- Benztropine Mesylate (AHFS DI)
- Benztropine (FDA)
- Benztropine Injection (FDA)
- Benztropine Mesylate (Wolters Kluwer)
Search Again
